Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
Authors
Keywords
-
Journal
Neurotherapeutics
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-23
DOI
10.1007/s13311-020-00926-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective Cohort
- (2020) Pierre Branger et al. Neurotherapeutics
- ACC1 (Acetyl Coenzyme A Carboxylase 1) Is a Potential Immune Modulatory Target of Cerebral Ischemic Stroke
- (2019) Xin Wang et al. STROKE
- High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice
- (2019) Laura Couloume et al. Multiple Sclerosis Journal
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
- (2018) Jerry S. Wolinsky et al. ANNALS OF NEUROLOGY
- Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France
- (2018) Sandra Vukusic et al. Multiple Sclerosis Journal
- Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study
- (2017) Kathryn Stiede et al. HEPATOLOGY
- Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
- (2017) Daniel Ontaneda et al. LANCET
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?
- (2016) J. Bonenfant et al. EUROPEAN JOURNAL OF NEUROLOGY
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
- (2016) Ayman Tourbah et al. Multiple Sclerosis Journal
- MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
- (2016) Ayman Tourbah et al. Multiple Sclerosis Journal
- High doses of biotin in chronic progressive multiple sclerosis: A pilot study
- (2015) Frédéric Sedel et al. Multiple Sclerosis and Related Disorders
- Structure and function of biotin-dependent carboxylases
- (2012) Liang Tong CELLULAR AND MOLECULAR LIFE SCIENCES
- Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS
- (2012) Robert J Fox et al. Multiple Sclerosis Journal
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More